Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023 Post published:March 21, 2023 Post category:Press Release
Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery Post published:March 21, 2023 Post category:Press Release
Psyence Partners with iNGENū for Palliative Care Clinical Trial in Australia Post published:March 21, 2023 Post category:Press Release
Algernon Pharmaceuticals Announces Launch of Rights Offering Post published:March 21, 2023 Post category:Press Release
Diamond Therapeutics Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin in Collaboration with University of Alabama at Birmingham Post published:March 21, 2023 Post category:Press Release
Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19 Post published:March 20, 2023 Post category:Press Release
Clearmind Medicine Submits IND Application to FDA for its Proprietary CMND-100 Treating Alcohol Use Disorder Post published:March 16, 2023 Post category:Press Release
MYDECINE INNOVATIONS GROUP ANNOUNCES COMMON SHARE SUBSCRIPTION AGREEMENT Post published:March 15, 2023 Post category:Press Release
Field Trip Health & Wellness to Close Clinics in 5 Locations Post published:March 15, 2023 Post category:Press Release
Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia Post published:March 15, 2023 Post category:Press Release